ClinicalTrials.Veeva

Menu

Study to Analyze the Efficacy of Acute Intake With a β-alanine Supplement in Recreational Cyclists (B-AC1)

U

Universidad Católica San Antonio de Murcia

Status

Completed

Conditions

Beta Alanine Supplementation

Treatments

Dietary Supplement: Beta Alanine low dose
Dietary Supplement: Beta Alanine high dose
Dietary Supplement: Control group

Study type

Interventional

Funder types

Other

Identifiers

NCT06180512
UCAMCFE-00029

Details and patient eligibility

About

Randomized, controlled, double-blind, single-center, double-blind clinical trial with three parallel arms depending on the product consumed (experimental product dose 1 and dose 2 and placebo product) to measure the efficacy of a sustained release beta alanine on physiological physical performance efficacy in recreational cyclists.

Full description

Subjects meeting the selection criteria will be randomly assigned to each of the study groups (investigational product dose 1 or dose 2, or placebo, depending on the group to which they have been assigned).

The product to be consumed is beta alanine. Participants will consume the product for 1 day. They will have to take four intakes every hour and a quarter, on the same day.

The study subjects will have to make 2 visits to the laboratory. In the first one, they will have to perform a 10-minute time trial, without consumption. In the second visit, they will perform the same performance test but with acute consumption of the product. Their physical and physiological performance will be evaluated.

The two tests will be separated by 7 days.

Enrollment

75 patients

Sex

Male

Ages

18 to 60 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Male cyclists with more than two years of cycling experience.
  • Perform tests without fatigue.
  • Road bike training at least twice a week.

Exclusion criteria

  • Participants with chronic illness.
  • Have a long-term injury that prevents you from training in the previous month.
  • Inability to understand informed consent.
  • Have consumed beta alanine in the three years prior to the start of the study.
  • Consumption of other supplements that may alter performance.

Trial design

Primary purpose

Other

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

75 participants in 3 patient groups, including a placebo group

Beta Alanine high dose
Experimental group
Description:
Consumption for 1 day.
Treatment:
Dietary Supplement: Beta Alanine high dose
Beta Alanine low dose
Experimental group
Description:
Consumption for 1 day.
Treatment:
Dietary Supplement: Beta Alanine low dose
Control group
Placebo Comparator group
Description:
Consumption for 1 day.
Treatment:
Dietary Supplement: Control group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems